APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antidote

Antidote is agent that counters the effects of poison or over dosage by another drug. It helps in neutralizing the dangerous effects of a poison in body and has scientific approaches that have been taken to assess the therapeutic value of antidotes.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antidote is agent that counters the effects of poison or over dosage by another drug. It helps in neutralizing the dangerous effects of a poison in body and has scientific approaches that have been taken to assess the therapeutic value of antidotes.

Selected research

Market Structure

Global Antidote Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchAntidote Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Antidote Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Antidote Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antidote Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Antidote Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Antidote is agent that counters the effects of poison or over dosage by another drug. It helps in neutralizing the dangerous effects of a poison in body and has scientific approaches that have been taken to assess the therapeutic value of antidotes.

Global Antidote key players include Roche, Pfizer, Bayer, etc. Global top three manufacturers hold a share about 15%.

North America is the largest market, with a share about 35%, followed by Europe and China, both have a share about 50 percent.

Read the full market overview

In terms of product, Chemical Antidotes is the largest segment, with a share about 45%. And in terms of application, the largest application is Pesticide Poisoning, followed by Heavy Metal Poisoning.

Report Includes

This report provides an overview of the global Antidote market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antidote and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antidote revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Antidote market size, projected growth trends, production technologies, key applications, and end-use industries.

Antidote Segment by Company

Roche

Pfizer

Bayer

Johnson & Johnson

Novartis

Eli Lilly

Teva

Boehringer Ingelheim

Mylan

Fresenius Kabi

Baxter

Furen Pharmaceutical

Antidote Segment by Type

Chemical Antidotes

Physical Antidotes

Pharmacological Antidotes

Antidote Segment by Application

Pesticide Poisoning

Heavy Metal Poisoning

Animal Bites Poisoning

Cyanide Poisoning

Others

Antidote Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidote market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antidote and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidote.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Antidote in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antidote industry.

Chapter 3: Detailed analysis of Antidote companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antidoterevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antidote Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Chemical Antidotes Table 3. Key Players of Physical Antidotes Table 4. Key Players of Pharmacological Antidotes Table 4. Global Antidote Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pesticide Poisoning Table 6. Key Players of Heavy Metal Poisoning Table 7. Key Players of Animal Bites Poisoning Table 8. Key Players of Cyanide Poisoning Table 9. Key Players of Others Table 10. Global Antidote Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Antidote Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Antidote Market Share by Region (2021-2026) Table 13. Global Antidote Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Antidote Market Share by Region (2027-2032) Table 15. Antidote Industry Trends Table 16. Antidote Industry Drivers Table 17. Antidote Industry Opportunities and Challenges Table 18. Antidote Industry Restraints Table 19. Global Antidote Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Antidote Revenue Market Share by Company (2021-2026) Table 21. Global Antidote Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Antidote Key Company Head Office and Area Served Table 23. Global Antidote Company, Product Type & Application Table 24. Global Antidote Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Antidote by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Antidote Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Antidote Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Antidote Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Antidote Revenue Market Share by Type (2021-2026) Table 31. Global Antidote Revenue Market Share by Type (2027-2032) Table 32. Global Antidote Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Antidote Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Antidote Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Antidote Revenue Market Share by Application (2021-2026) Table 36. Global Antidote Revenue Market Share by Application (2027-2032) Table 37. Roche Company Information Table 38. Roche Business Overview Table 39. Roche Antidote Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Roche Antidote Product Portfolio Table 41. Roche Recent Development Table 42. Pfizer Company Information Table 43. Pfizer Business Overview Table 44. Pfizer Antidote Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Pfizer Antidote Product Portfolio Table 46. Pfizer Recent Development Table 47. Bayer Company Information Table 48. Bayer Business Overview Table 49. Bayer Antidote Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Bayer Antidote Product Portfolio Table 51. Bayer Recent Development Table 52. Johnson & Johnson Company Information Table 53. Johnson & Johnson Business Overview Table 54. Johnson & Johnson Antidote Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Johnson & Johnson Antidote Product Portfolio Table 56. Johnson & Johnson Recent Development Table 57. Novartis Company Information Table 58. Novartis Business Overview Table 59. Novartis Antidote Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Novartis Antidote Product Portfolio Table 61. Novartis Recent Development Table 62. Eli Lilly Company Information Table 63. Eli Lilly Business Overview Table 64. Eli Lilly Antidote Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Eli Lilly Antidote Product Portfolio Table 66. Eli Lilly Recent Development Table 67. Teva Company Information Table 68. Teva Business Overview Table 69. Teva Antidote Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Teva Antidote Product Portfolio Table 71. Teva Recent Development Table 72. Boehringer Ingelheim Company Information Table 73. Boehringer Ingelheim Business Overview Table 74. Boehringer Ingelheim Antidote Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Boehringer Ingelheim Antidote Product Portfolio Table 76. Boehringer Ingelheim Recent Development Table 77. Mylan Company Information Table 78. Mylan Business Overview Table 79. Mylan Antidote Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Mylan Antidote Product Portfolio Table 81. Mylan Recent Development Table 82. Fresenius Kabi Company Information Table 83. Fresenius Kabi Business Overview Table 84. Fresenius Kabi Antidote Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Fresenius Kabi Antidote Product Portfolio Table 86. Fresenius Kabi Recent Development Table 87. Baxter Company Information Table 88. Baxter Business Overview Table 89. Baxter Antidote Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Baxter Antidote Product Portfolio Table 91. Baxter Recent Development Table 92. Furen Pharmaceutical Company Information Table 93. Furen Pharmaceutical Business Overview Table 94. Furen Pharmaceutical Antidote Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Furen Pharmaceutical Antidote Product Portfolio Table 96. Furen Pharmaceutical Recent Development Table 97. North America Antidote Market Size by Type (2021-2026) & (US$ Million) Table 98. North America Antidote Market Size by Type (2027-2032) & (US$ Million) Table 99. North America Antidote Market Size by Application (2021-2026) & (US$ Million) Table 100. North America Antidote Market Size by Application (2027-2032) & (US$ Million) Table 101. North America Antidote Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Antidote Market Size by Country (2021-2026) Table 103. North America Antidote Market Size by Country (2027-2032) Table 104. Europe Antidote Market Size by Type (2021-2026) & (US$ Million) Table 105. Europe Antidote Market Size by Type (2027-2032) & (US$ Million) Table 106. Europe Antidote Market Size by Application (2021-2026) & (US$ Million) Table 107. Europe Antidote Market Size by Application (2027-2032) & (US$ Million) Table 108. Europe Antidote Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe Antidote Market Size by Country (2021-2026) Table 110. Europe Antidote Market Size by Country (2027-2032) Table 111. China Antidote Market Size by Type (2021-2026) & (US$ Million) Table 112. China Antidote Market Size by Type (2027-2032) & (US$ Million) Table 113. China Antidote Market Size by Application (2021-2026) & (US$ Million) Table 114. China Antidote Market Size by Application (2027-2032) & (US$ Million) Table 115. Asia Antidote Market Size by Type (2021-2026) & (US$ Million) Table 116. Asia Antidote Market Size by Type (2027-2032) & (US$ Million) Table 117. Asia Antidote Market Size by Application (2021-2026) & (US$ Million) Table 118. Asia Antidote Market Size by Application (2027-2032) & (US$ Million) Table 119. Asia Antidote Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Asia Antidote Market Size by Country (2021-2026) Table 121. Asia Antidote Market Size by Country (2027-2032) Table 122. South America, Middle East & Africa Antidote Market Size by Type (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Antidote Market Size by Type (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Antidote Market Size by Application (2021-2026) & (US$ Million) Table 125. South America, Middle East & Africa Antidote Market Size by Application (2027-2032) & (US$ Million) Table 126. South America, Middle East & Africa Antidote Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. South America, Middle East & Africa Antidote Market Size by Country (2021-2026) Table 128. South America, Middle East & Africa Antidote Market Size by Country (2027-2032) Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Antidote Product Image Figure 2. Global Antidote Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Antidote Market Share by Type: 2025 VS 2032 Figure 4. Chemical Antidotes Image Figure 5. Physical Antidotes Image Figure 6. Pharmacological Antidotes Image Figure 7. Global Antidote Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Antidote Market Share by Application: 2025 VS 2032 Figure 9. Pesticide Poisoning Image Figure 10. Heavy Metal Poisoning Image Figure 11. Animal Bites Poisoning Image Figure 12. Cyanide Poisoning Image Figure 13. Others Image Figure 14. Global Antidote Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Antidote Market Size (2021-2032) & (US$ Million) Figure 16. Global Antidote Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Antidote Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Antidote Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Antidote Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Antidote Revenue Market Share by Type (2021-2032) Figure 23. Global Antidote Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Antidote Revenue Market Share by Application (2021-2032) Figure 25. North America Antidote Market Size (2021-2032) & (US$ Million) Figure 26. North America Antidote Market Share by Type (2021-2032) Figure 27. North America Antidote Market Share by Application (2021-2032) Figure 28. North America Antidote Market Share by Country (2021-2032) Figure 29. United States Antidote Market Size (2021-2032) & (US$ Million) Figure 30. Canada Antidote Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Antidote Market Size (2021-2032) & (US$ Million) Figure 32. Europe Antidote Market Size (2021-2032) & (US$ Million) Figure 33. Europe Antidote Market Share by Type (2021-2032) Figure 34. Europe Antidote Market Share by Application (2021-2032) Figure 35. Europe Antidote Market Share by Country (2021-2032) Figure 36. Germany Antidote Market Size (2021-2032) & (US$ Million) Figure 37. France Antidote Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Antidote Market Size (2021-2032) & (US$ Million) Figure 39. Italy Antidote Market Size (2021-2032) & (US$ Million) Figure 40. Russia Antidote Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Antidote Market Size (2021-2032) & (US$ Million) Figure 42. China Antidote Market Size (2021-2032) & (US$ Million) Figure 43. China Antidote Market Share by Type (2021-2032) Figure 44. China Antidote Market Share by Application (2021-2032) Figure 45. Asia Antidote Market Size (2021-2032) & (US$ Million) Figure 46. Asia Antidote Market Share by Type (2021-2032) Figure 47. Asia Antidote Market Share by Application (2021-2032) Figure 48. Asia Antidote Market Share by Country (2021-2032) Figure 49. Japan Antidote Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Antidote Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Antidote Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Antidote Market Size (2021-2032) & (US$ Million) Figure 53. India Antidote Market Size (2021-2032) & (US$ Million) Figure 54. Australia Antidote Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Antidote Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Antidote Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Antidote Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Antidote Market Share by Country (2021-2032) Figure 59. Brazil Antidote Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Antidote Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Antidote Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Antidote Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Antidote Market Size (2021-2032) & (US$ Million) Figure 64. UAE Antidote Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Antidote Market Size (2021-2032) & (US$ Million) Figure 66. Chile Antidote Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Chemical Antidotes
  • Physical Antidotes
  • Pharmacological Antidotes
Applications
  • Pesticide Poisoning
  • Heavy Metal Poisoning
  • Animal Bites Poisoning
  • Cyanide Poisoning
  • Others
Companies covered
  • Roche
  • Pfizer
  • Bayer
  • Johnson & Johnson
  • Novartis
  • Eli Lilly
  • Teva
  • Boehringer Ingelheim
  • Mylan
  • Fresenius Kabi
  • Baxter
  • Furen Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Antidote Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Chemical Antidotes
  5. 1.2.3 Physical Antidotes
  6. 1.2.4 Pharmacological Antidotes
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Antidote Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Pesticide Poisoning
  10. 1.3.3 Heavy Metal Poisoning
  11. 1.3.4 Animal Bites Poisoning
  12. 1.3.5 Cyanide Poisoning
  13. 1.3.6 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Antidote Growth Trends by Region
  16. 1.5.1 Global Antidote Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Antidote Market Size by Region (2021-2026)
  18. 1.5.3 Antidote Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Antidote Market Dynamics
  1. 2.1 Antidote Industry Trends
  2. 2.2 Antidote Industry Drivers
  3. 2.3 Antidote Industry Opportunities and Challenges
  4. 2.4 Antidote Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Antidote Revenue by Company (2021-2026)
  2. 3.2 Global Antidote Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Antidote Key Company Head office and Area Served
  4. 3.4 Global Antidote Company, Product Type & Application
  5. 3.5 Global Antidote Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Antidote Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Antidote Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Antidote Tier 1, Tier 2, and Tier 3
4 Antidote Market by Type
  1. 4.1 Global Antidote Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Antidote Market Size by Type (2021-2032)
  3. 4.3 Global Antidote Market Size Share by Type (2021-2032)
5 Antidote Market by Application
  1. 5.1 Global Antidote Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Antidote Market Size by Application (2021-2032)
  3. 5.3 Global Antidote Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Antidote Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Roche Antidote Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Antidote Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Pfizer Antidote Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Antidote Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bayer Antidote Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Antidote Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Johnson & Johnson Antidote Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Antidote Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Novartis Antidote Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Eli Lilly
  32. 6.6.1 Eli Lilly Company Information
  33. 6.6.2 Eli Lilly Business Overview
  34. 6.6.3 Eli Lilly Antidote Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Eli Lilly Antidote Product Portfolio
  36. 6.6.5 Eli Lilly Recent Developments
  37. 6.7 Teva
  38. 6.7.1 Teva Company Information
  39. 6.7.2 Teva Business Overview
  40. 6.7.3 Teva Antidote Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Teva Antidote Product Portfolio
  42. 6.7.5 Teva Recent Developments
  43. 6.8 Boehringer Ingelheim
  44. 6.8.1 Boehringer Ingelheim Company Information
  45. 6.8.2 Boehringer Ingelheim Business Overview
  46. 6.8.3 Boehringer Ingelheim Antidote Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Boehringer Ingelheim Antidote Product Portfolio
  48. 6.8.5 Boehringer Ingelheim Recent Developments
  49. 6.9 Mylan
  50. 6.9.1 Mylan Company Information
  51. 6.9.2 Mylan Business Overview
  52. 6.9.3 Mylan Antidote Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Mylan Antidote Product Portfolio
  54. 6.9.5 Mylan Recent Developments
  55. 6.10 Fresenius Kabi
  56. 6.10.1 Fresenius Kabi Company Information
  57. 6.10.2 Fresenius Kabi Business Overview
  58. 6.10.3 Fresenius Kabi Antidote Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Fresenius Kabi Antidote Product Portfolio
  60. 6.10.5 Fresenius Kabi Recent Developments
  61. 6.11 Baxter
  62. 6.11.1 Baxter Company Information
  63. 6.11.2 Baxter Business Overview
  64. 6.11.3 Baxter Antidote Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Baxter Antidote Product Portfolio
  66. 6.11.5 Baxter Recent Developments
  67. 6.12 Furen Pharmaceutical
  68. 6.12.1 Furen Pharmaceutical Company Information
  69. 6.12.2 Furen Pharmaceutical Business Overview
  70. 6.12.3 Furen Pharmaceutical Antidote Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Furen Pharmaceutical Antidote Product Portfolio
  72. 6.12.5 Furen Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Antidote Market Size (2021-2032)
  2. 7.2 North America Antidote Market Size by Type
  3. 7.2.1 North America Antidote Market Size by Type (2021-2026)
  4. 7.2.2 North America Antidote Market Size by Type (2027-2032)
  5. 7.2.3 North America Antidote Market Share by Type (2021-2032)
  6. 7.3 North America Antidote Market Size by Application
  7. 7.3.1 North America Antidote Market Size by Application (2021-2026)
  8. 7.3.2 North America Antidote Market Size by Application (2027-2032)
  9. 7.3.3 North America Antidote Market Share by Application (2021-2032)
  10. 7.4 North America Antidote Market Size by Country
  11. 7.4.1 North America Antidote Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Antidote Market Size by Country (2021-2026)
  13. 7.4.3 North America Antidote Market Size by Country (2027-2032)
  14. 7.4.4 North America Antidote Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Antidote Market Size (2021-2032)
  2. 8.2 Europe Antidote Market Size by Type
  3. 8.2.1 Europe Antidote Market Size by Type (2021-2026)
  4. 8.2.2 Europe Antidote Market Size by Type (2027-2032)
  5. 8.2.3 Europe Antidote Market Share by Type (2021-2032)
  6. 8.3 Europe Antidote Market Size by Application
  7. 8.3.1 Europe Antidote Market Size by Application (2021-2026)
  8. 8.3.2 Europe Antidote Market Size by Application (2027-2032)
  9. 8.3.3 Europe Antidote Market Share by Application (2021-2032)
  10. 8.4 Europe Antidote Market Size by Country
  11. 8.4.1 Europe Antidote Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Antidote Market Size by Country (2021-2026)
  13. 8.4.3 Europe Antidote Market Size by Country (2027-2032)
  14. 8.4.4 Europe Antidote Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Antidote Market Size (2021-2032)
  2. 9.2 China Antidote Market Size by Type
  3. 9.2.1 China Antidote Market Size by Type (2021-2026)
  4. 9.2.2 China Antidote Market Size by Type (2027-2032)
  5. 9.2.3 China Antidote Market Share by Type (2021-2032)
  6. 9.3 China Antidote Market Size by Application
  7. 9.3.1 China Antidote Market Size by Application (2021-2026)
  8. 9.3.2 China Antidote Market Size by Application (2027-2032)
  9. 9.3.3 China Antidote Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Antidote Market Size (2021-2032)
  2. 10.2 Asia Antidote Market Size by Type
  3. 10.2.1 Asia Antidote Market Size by Type (2021-2026)
  4. 10.2.2 Asia Antidote Market Size by Type (2027-2032)
  5. 10.2.3 Asia Antidote Market Share by Type (2021-2032)
  6. 10.3 Asia Antidote Market Size by Application
  7. 10.3.1 Asia Antidote Market Size by Application (2021-2026)
  8. 10.3.2 Asia Antidote Market Size by Application (2027-2032)
  9. 10.3.3 Asia Antidote Market Share by Application (2021-2032)
  10. 10.4 Asia Antidote Market Size by Country
  11. 10.4.1 Asia Antidote Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Antidote Market Size by Country (2021-2026)
  13. 10.4.3 Asia Antidote Market Size by Country (2027-2032)
  14. 10.4.4 Asia Antidote Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Antidote Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Antidote Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Antidote Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Antidote Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Antidote Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Antidote Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Antidote Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Antidote Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Antidote Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Antidote Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Antidote Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Antidote Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Antidote Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Antidote Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst